| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PharmaCyte Biotech Inc. Common Stock (NASDAQ: PMCB)
PMCB Technical Analysis
5
| As on 9th Jun 2023 PMCB STOCK Price closed @ 3.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.41 & Strong Buy for SHORT-TERM with Stoploss of 2.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PMCBSTOCK Price
| Open | 3.18 | Change | Price | % |
| High | 3.18 | 1 Day | -0.03 | -0.94 |
| Low | 3.03 | 1 Week | 0.00 | 0.00 |
| Close | 3.15 | 1 Month | 0.19 | 6.42 |
| Volume | 70362 | 1 Year | 0.53 | 20.23 |
| 52 Week High 3.18 | 52 Week Low 1.91 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PMCB Daily Charts |
PMCB Intraday Charts |
Whats New @ Bazaartrend |
PMCB Free Analysis |
|
|
PMCB Important Levels Intraday
| RESISTANCE | 3.44 |
| RESISTANCE | 3.35 |
| RESISTANCE | 3.29 |
| RESISTANCE | 3.23 |
| SUPPORT | 3.07 |
| SUPPORT | 3.01 |
| SUPPORT | 2.95 |
| SUPPORT | 2.86 |
PMCB Forecast April 2024
| 4th UP Forecast | 4.34 |
| 3rd UP Forecast | 3.96 |
| 2nd UP Forecast | 3.72 |
| 1st UP Forecast | 3.49 |
| 1st DOWN Forecast | 2.81 |
| 2nd DOWN Forecast | 2.58 |
| 3rd DOWN Forecast | 2.34 |
| 4th DOWN Forecast | 1.96 |
PMCB Weekly Forecast
| 4th UP Forecast | 3.92 |
| 3rd UP Forecast | 3.67 |
| 2nd UP Forecast | 3.52 |
| 1st UP Forecast | 3.37 |
| 1st DOWN Forecast | 2.93 |
| 2nd DOWN Forecast | 2.78 |
| 3rd DOWN Forecast | 2.63 |
| 4th DOWN Forecast | 2.38 |
PMCB Forecast2024
| 4th UP Forecast | 5.92 |
| 3rd UP Forecast | 5.03 |
| 2nd UP Forecast | 4.48 |
| 1st UP Forecast | 3.93 |
| 1st DOWN Forecast | 2.37 |
| 2nd DOWN Forecast | 1.82 |
| 3rd DOWN Forecast | 1.27 |
| 4th DOWN Forecast | 0.38 |
PharmaCyte Biotech Inc. Common Stock ( NASDAQ USA Symbol : PMCB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PMCB Business Profile
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other tumors, including encapsulated genetically modified living cells. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant. The company has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is based in Laguna Hills, California. Address: 23046 Avenida de la Carlota, Laguna Hills, CA, United States, 92653
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service